Lemaitre Vascular (LMAT) Other Operating Expenses (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Other Operating Expenses data on file, last reported at $14.5 million in Q1 2026.

• Quarterly Other Operating Expenses rose 2.13% year-over-year to $14.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.8 million (up 11.17% YoY) and the FY2025 annual result came in at $54.5 million, up 16.53% from the prior year.
• Other Operating Expenses grew to $14.5 million in Q1 2026 per LMAT's latest filing, from $13.4 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $14.9 million in Q2 2025 and bottomed at $7.8 million in Q1 2022.
• The 5-year median for Other Operating Expenses is $11.3 million (2022), against an average of $11.4 million.
• The widest annual swing landed in 2022, when Other Operating Expenses surged 199.05%; it then dropped 8.4% in 2023.
• Tracing LMAT's Other Operating Expenses over 5 years: stood at $8.6 million in 2022, then climbed by 19.4% to $10.3 million in 2023, then climbed by 22.96% to $12.6 million in 2024, then gained by 6.4% to $13.4 million in 2025, then rose by 8.05% to $14.5 million in 2026.
• Per Business Quant, the three latest LMAT Other Operating Expenses figures stand at $14.5 million (Q1 2026), $13.4 million (Q4 2025), and $11.9 million (Q3 2025).

Peer Comparison